Clinical trial
A Prospective, Open-Label, Randomized Controlled Trial of an Artificial Intelligence Enabled Electrocardiography System for Preoperative Detection of Pulmonary Hypertension and Related Diseases(GUARD-PH)
NCT07344207 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open-Label, Randomized Controlled Trial of an Artificial Intelligence Enabled Electrocardiography System for Preoperative Detection of Pulmonary Hypertension and Related Diseases(GUARD-PH)
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 5, 2026
- Completion date
- January 5, 2027
- Enrollment
- 1,380 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative complications (cardiopulmonary), pre-operative assessment, pulmonary hypertension (diagnosis), treatment outcomes